GGrantIndex
← Leaderboards

Michael Ghaly

Radiopharmaceutical Imaging And Dosimetry, Llc

$5,273,687
Attributed
$8,450,399
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY201725
$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,450,399 · 9

By mechanism

R44$4,519,312 · 3
N44$1,999,796 · 1
R43$1,025,728 · 3
R01$606,288 · 1
N43$299,275 · 1

Top collaborators

Others in their field

Other Emerging Leaders on “Dosimetry

Research focus

DosimetryDesignRadiopharmaceuticalsServicesDoseRadiationComputer SoftwareCloud BasedModalityRadioisotopesCancer CellCancer TherapyPharmacologic SubstanceTumorInterestOrganClinical TrialsLicensingBaseTreatment PlanningAreaReconstructionPharmaceutical PreparationsClient

Grant awards (13)

Cloud/Web-Based Platform for Quantitative SPECT Reconstruction of Therapeutic Radionuclides$1,003,173
R44 · FY2025 · CA · contact PI
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$749,606
R44 · FY2025 · CA · contact PI
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$898,497
R44 · FY2024 · CA · contact PI
Hyperspectral Single Photon Imaging of Targeted Alpha-Emitters$606,288
R01 · FY2024 · EB
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$706,019
R44 · FY2021 · CA · contact PI
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$162,019
R44 · FY2020 · CA · contact PI
TOPIC 368: TREATMENT OPTIMIZATION BY COMBINED A-EMITTER (ARPT)/RADIOTHERAPY (XRT) DOSIMETRY FOR PROSTATE CANCER PATIENTS$1,999,796
N44 · FY2019 · CA · contact PI
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$999,998
R44 · FY2019 · CA · contact PI
SBIR PHASE I TOPIC 392: TARGETED RADIONUCLIDE THERAPY OF METASTATIC LIVER CANCER: PATIENT SPECIFIC OPTIMIZATION$299,275
N43 · FY2019 · CA · contact PI
Quantitative SPECT of Difficult to Image Therapeutic Radionuclides: An Extensible Cloud-Based Framework$299,995
R43 · FY2018 · CA · contact PI
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$293,774
R43 · FY2018 · CA · contact PI
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy$131,959
R43 · FY2018 · CA · contact PI
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy$300,000
R43 · FY2017 · CA · contact PI